Navigation Links
Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies

CANTON, Ohio, June 19, 2013 /PRNewswire/ -- Mercy Medical Center recently implemented advanced clinical laboratory diagnostics technology for conducting on-demand, Hemoglobin A1c (HbA1c) diabetes testing, as well as analysis of important red blood cell, white blood cell and platelet counts. The new system enables the hospital to provide faster, more accurate lab results for physicians and their patients, which can improve treatment decisions.  


As North America's first installation of its kind, the Sysmex Lavender Top Management® system, designed and manufactured by Bio-Rad Laboratories, Inc. (NYSE:   BIO and BIOb) and Sysmex America, builds on Mercy's Sysmex XN-9000™system and further optimizes lab workflow, staffing and space.

Mary Ann Burich-Boccia, administrative director of Mercy Laboratory Services, believes upgrading and standardizing the lab with the XN-9000 Lavender Top Management configuration means the hospital can continue to stay ahead of testing complexities and provide quality HbA1c testing and results on a 24/7 basis.

"This powerful new platform will greatly benefit patients in our community, many of whom suffer from diabetes, and it will contribute to positive patient outcomes," she says. "Our previous platform was the original Lavender Top Management, and we were able to achieve all our expected productivity gains. The XN-9000 allows us to continue to improve even further."

New System Incorporates Latest in Automation Technology

The XN-9000, a scalable, configurable automation system, integrates multiple XN modules, including the Sysmex RU-20™ concentrated reagent dilution unit; sample sorting and archiving provided by the PVT LabSystems® TS-500; WAM™ decision support software; and Bio-Rad's VARIANT™ II TURBO Link for on-demand HbA1c testing.

With its new system, Mercy will also perform:

  • NRBCs (fluorescent nucleated red blood cell count) with every CBC (complete blood count)
  • IG (Immature granulocyte enumeration) with every differential
  • RET-He (Reticulocyte hemoglobin) as a parameter in the reticulocyte profile
  • IPF (Immature platelet fraction) to aid clinicians in the assessment of thrombocytopenia

XN-9000 Plays Critical Role in Determining Diabetes Control

The XN-9000 uses HPLC (high-performance liquid chromatography) technology – the gold standard for HbA1c testing – to perform HbA1c analysis, which measures the amount of glucose attached to the hemoglobin in the red blood cell and estimates blood glucose control during the previous three to four months. 

According to the American Diabetes Association, diabetes affects more than 25 million children and adults in the United States, or 8.3 percent of the population. It can increase a person's risk for developing serious complications, including heart disease and stroke, high blood pressure, blindness, kidney and nervous system diseases. Proper management of the chronic condition can delay or even prevent the onset of complications, allowing patients to live healthier, more productive lives.

About Mercy Medical Center

Mercy Medical Center, a ministry of the Sisters of Charity Health System, operates a 476-bed hospital serving Stark, Carroll, Wayne, Holmes and Tuscarawas Counties and parts of Southeastern Ohio. It has 620 members on its Medical Staff and employs 2,500 people. Mercy operates outpatient health centers in Carroll County, Jackson Township, Lake Township, Louisville, North Canton, Plain Township and Tuscarawas County. A Catholic hospital, Mercy Medical Center upholds the mission and philosophy of the Sisters of Charity of St. Augustine and continues to be responsive to the needs of the community. For more information, see

About Sysmex America, Inc.

Sysmex America, Inc., the U.S. headquarters of Sysmex Corporation (Kobe, Japan), is a world leader in clinical laboratory systemization and solutions, including clinical diagnostics, automation and information systems. Serving customers for over 40 years, Sysmex focuses on extending the boundaries of diagnostic science while providing the management information tools that make a real difference in clinical and operational results for people worldwide. For more information about Sysmex, please visit  Stay connected with Sysmex America on Facebook, Twitter, LinkedIn and YouTube.

Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Mercyhurst Universitys new DNA sequencer to accelerate scientific research in region
2. Mercyhurst University study probes impact of climate change on ectotherms
3. Grant furthers Mercyhurst research for human pathogens in Great Lakes
4. Gene offers an athletes heart without the exercise
5. New report offers science-based strategies for management of western free-ranging horses and burros
6. Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system
7. AegisCare Offers Specialized Home Health Care for Dementia and Alzheimers Patients
8. Bird flu mutation study offers vaccine clue
9. Researcher offers clues on the origins of life
10. Peach genome offers insights into breeding strategies for biofuels crops
11. Study offers new insights on invasive fly threatening US fruit crops
Post Your Comments:
(Date:11/16/2015)... 16, 2015  Synaptics Inc. (NASDAQ: SYNA ... today announced expansion of its TDDI product portfolio ... controller and display driver integration (TDDI) solutions designed ... new TDDI products add to the previously-announced ... (WQHD resolution), and TD4322 (FHD resolution) solutions. All ...
(Date:11/10/2015)... LONDON , Nov. 10, 2015 /PRNewswire/ ... segmented on the basis of product, type, ... segments included in this report are consumables, ... this report are safety biomarkers, efficacy biomarkers, ... in this report are diagnostics development, drug ...
(Date:11/2/2015)... Nov. 2, 2015  SRI International has been awarded ... preclinical development services to the National Cancer Institute (NCI) ... provide scientific expertise, modern testing and support facilities, and ... pharmacology and toxicology studies to evaluate potential cancer prevention ... The PREVENT Cancer Drug Development Program is an NCI-supported ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... DIEGO , Nov. 25, 2015 Orexigen® ... management will participate in a fireside chat discussion at ... New York . The discussion is scheduled ... .  A replay will be ... Media Contact:McDavid Stilwell  , Julie NormartVP, Corporate Communications ...
(Date:11/24/2015)... SUNNYVALE, Calif. , Nov. 24, 2015 ... executives will be speaking at the following conference, and ... New York, NY      Tuesday, December 1, ... New York, NY      Tuesday, December 1, ...      Piper Jaffray Healthcare Conference, New York, NY ...
(Date:11/24/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) ... of the Toronto Stock Exchange, confirms that as of ... corporate developments that would cause the recent movements in ... --> About Aeterna Zentaris Inc. ... Aeterna Zentaris is a specialty biopharmaceutical company engaged ...
(Date:11/24/2015)... Massachusetts , November 24, 2015 SHPG ... will participate in the Piper Jaffray 27 th Annual Healthcare ... Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 p.m. GMT). ... , Chief Financial Officer, will participate in the Piper Jaffray 27 ... , NY on Tuesday, December 1, 2015, at 8:30 a.m. ...
Breaking Biology Technology: